Contact Us
Find A Doctor

Mycophenolate Mofetil Chronic Non-Infectious Uveitis Treatment Study

Principal Investigator

C. Michael Samson, M.D.

Enrollment Status

Completed

Objective

To determine if CellCept is as effective or more effective than Methotrexate in treating uveitis. This is a randomized, masked, controlled comparative trial against Methotrexate.

Conclusion

The data generates concordant evidence with other SUN-compliant studies supporting the use of Mycophenolate Mofetil in uveitis.

For more information:

http://www.clinicaltrials.gov

Contact Us

Dr. C. Michael Samson, Principal Investigator

Katy Tai, Research ManagerTel: (212) 979-4251

Address310 E. 14th StreetNew York, NY 10003

View all locations